Warfarin related intracranial haemorrhage: A case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage

Journal of Clinical Neuroscience

Volumn 16, Issue 7, 2009, Pages 882-885

  Jeffree, R L ^a   Gordon, D H ^a   Sivasubramaniam, R ^a   Chapman, A ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Anticoagulants; Cerebral haemorrhage; Complications; International normalized ratio; Intracranial haemorrhage; Subdural hematoma; Warfarin

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBDURAL HEMATOMA;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; DRUG MONITORING; FEMALE; HEMATOMA, SUBDURAL; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 67349183391     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.10.004     Document Type: Article

References (23)

1. Palareti G., Leali N., Coccheri S., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348 (1996) 423-428
2. Hart R.G., Tonarelli S.B., and Pearce L.A. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36 (2005) 1588-1593
3. Gallus A.S., Baker R.I., Chong B.H., et al. Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis. Med J Austr 172 (2000) 600-605
4. Nicolini A., Ghirarduzzi A., Iorio A., et al. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 87 (2002) 948-956
5. Radberg J.A., Olsson J.E., and Radberg C.T. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22 (1991) 571-576
6. Schutz H., Bodeker R.H., Damian M., et al. Age-related spontaneous intracerebral hematoma in a German community. Stroke 21 (1990) 1412-1418
7. Flibotte J.J., Hagan N., O'Donnell J., et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63 (2004) 1059-1064
8. Stroke Prevention in Atrial Fibrillation II Study Group. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343 (1994) 687-691
9. Flaherty M.L., Kissela B., Woo D., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68 (2007) 116-121
10. Berwaerts J., and Webster J. Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages. QJM 93 (2000) 513-521
11. Singer D.E., and Go A.S. Antithrombotic therapy in atrial fibrillation. Clin Geriatric Med 17 (2001) 131-147
12. Landefeld C.S., and Beyth R.J. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 95 (1993) 315-328
13. Njaastad A.M., Abildgaard U., and Lassen J.F. Gains and losses of warfarin therapy as performed in an anticoagulation clinic. J Int Med 259 (2006) 296-304
14. van der Meer F.J., Rosendaal F.R., Vandenbroucke J.P., et al. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Int Med 153 (1993) 1557-1562
15. Fihn S.D., McDonell M., Martin D., et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Int Med 118 (1993) 511-520
16. E. Donohoo (Ed.). MiMS Annual. Sydney: CMPMedica; 2007.
17. Nilsson O.G., Lindgren A., Stahl N., et al. Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 69 (2000) 601-607
18. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Int Med 164 (2004) 880-884
19. Hylek E.M., and Singer D.E. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Int Med 120 (1994) 897-902
20. Fang M.C., Chang Y., Hylek E.M., et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Int Med 141 (2004) 745-752
21. Folkeringa R.J., Dinh T.N., and Crijns H.J. Oral anticoagulation and stroke in atrial fibrillation. New Engl J Med 349 (2003) 2360-2361 author reply 2360-1
22. Medicare Australia Statistical Reporting [Database on the Internet] Australian Government c. 2007 [accessed 2007 December 28] Available from www.medicareaustralia.gov.au/statistics/dyn_pbs/forms/pbs_tab1.shtml.
23. Australian Bureau of Statistics. [Internet] 3101.0 Australian Demographic Statistics. Canberra: Commonwealth of Australia. Updated September 2007 [accessed 2007 December 28] Available from http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Sep%202007?OpenDocument.